Vascular involvement in systemic sclerosis (scleroderma)
Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of Veterans Affairs Medical Center, Memphis, TN, USAA...
Guardado en:
Autores principales: | Pattanaik D, Brown M, Postlethwaite AE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f2ad46947d94c52a6cd3a2d21f4600c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez Ó
Publicado: (2014) -
Emerging therapies for treatment of multiple sclerosis
por: John R Corboy, et al.
Publicado: (2010) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Afsaneh Shirani, et al.
Publicado: (2010) -
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Slobodan M Jankovic
Publicado: (2010) -
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients [Corrigendum]
por: Taheri M, et al.
Publicado: (2019)